Literature DB >> 9166741

4-hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake.

J E Springer1, R D Azbill, R J Mark, J G Begley, G Waeg, M P Mattson.   

Abstract

Traumatic injury to the spinal cord initiates a host of pathophysiological events that are secondary to the initial insult. One such event is the accumulation of free radicals that damage lipids, proteins, and nucleic acids. A major reactive product formed following lipid peroxidation is the aldehyde, 4-hydroxynonenal (HNE), which cross-links to side chain amino acids and inhibits the function of several key metabolic enzymes. In the present study, we used immunocytochemical and immunoblotting techniques to examine the accumulation of protein-bound HNE, and synaptosomal preparations to study the effects of spinal cord injury and HNE formation on glutamate uptake. Protein-bound HNE increased in content in the damaged spinal cord at early times following injury (1-24 h) and was found to accumulate in myelinated fibers distant to the site of injury. Immunoblots revealed that protein-bound HNE levels increased dramatically over the same postinjury interval. Glutamate uptake in synaptosomal preparations from injured spinal cords was decreased by 65% at 24 h following injury. Treatment of control spinal cord synaptosomes with HNE was found to decrease significantly, in a dose-dependent fashion, glutamate uptake, an effect that was mimicked by inducers of lipid peroxidation. Taken together, these findings demonstrate that the lipid peroxidation product HNE rapidly accumulates in the spinal cord following injury and that a major consequence of HNE accumulation is a decrease in glutamate uptake, which may potentiate neuronal cell dysfunction and death through excitotoxic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166741     DOI: 10.1046/j.1471-4159.1997.68062469.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  44 in total

Review 1.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

Review 2.  Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy.

Authors:  Nicola J Allen; Ragnhildur Káradóttir; David Attwell
Journal:  Pflugers Arch       Date:  2004-08-24       Impact factor: 3.657

3.  MK-801 effect on regional cerebral oxidative stress rate induced by different duration of global ischemia in gerbils.

Authors:  Vesna Selakovic; Branka Janac; Lidija Radenovic
Journal:  Mol Cell Biochem       Date:  2010-04-27       Impact factor: 3.396

4.  Stability, disposition, and penetration of catalytic antioxidants Mn-porphyrin and Mn-salen and of methylprednisolone in spinal cord injury.

Authors:  Liqin Wu; Yichu Shan; Danxia Liu
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-06

Review 5.  Molecular mechanisms of acrolein-mediated myelin destruction in CNS trauma and disease.

Authors:  R Shi; J C Page; M Tully
Journal:  Free Radic Res       Date:  2015-04-16

Review 6.  Antioxidant therapies for acute spinal cord injury.

Authors:  Edward D Hall
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

7.  Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?

Authors:  Glen B Baker; Bernard Sowa; Kathryn G Todd
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186

Review 8.  Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

Authors:  Dustin J Donnelly; Phillip G Popovich
Journal:  Exp Neurol       Date:  2007-06-30       Impact factor: 5.330

9.  The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury.

Authors:  Joe E Springer; Ravikumar Rangaswamy Rao; Hyang Ran Lim; Sung Ig Cho; Gyoeng Joon Moon; Hee Young Lee; Eui Jin Park; Jai Sung Noh; Byoung Joo Gwag
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

10.  N-acetylcysteine amide preserves mitochondrial bioenergetics and improves functional recovery following spinal trauma.

Authors:  Samir P Patel; Patrick G Sullivan; Jignesh D Pandya; Glenn A Goldstein; Jenna L VanRooyen; Heather M Yonutas; Khalid C Eldahan; Johnny Morehouse; David S K Magnuson; Alexander G Rabchevsky
Journal:  Exp Neurol       Date:  2014-05-05       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.